Nurix Therapeutics, Inc. NRIX Unrecognized Tax Benefits
Unrecognized Tax Benefits at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefits.
The official record: Nurix Therapeutics, Inc.’s 10-K, filed January 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s unrecognized tax benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s unrecognized tax benefits?
- Nurix Therapeutics, Inc. (NRIX) reported unrecognized tax benefits of $32.31M in Q3 2025.
- What is the long-term trend for Nurix Therapeutics, Inc.'s unrecognized tax benefits?
- Over 3 years (2022 to 2025), Nurix Therapeutics, Inc.'s unrecognized tax benefits has grown at a 46.6% compound annual growth rate (CAGR), from $10.26M to $32.31M.
- What does unrecognized tax benefits mean?
- This represents the amount of tax benefits from uncertain tax positions that have not been recognized in the financial statements because they do not meet the 'more-likely-than-not' threshold. It reflects the company's exposure to potential tax audits and disputes with tax authorities. This is a key indicator of tax-related legal and financial risk.